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Wan-Seob Cho1,2, Rodger Duffin1, Mark Bradley3, Ian L Megson4, William MacNee1, Jong Kwon Lee5,
Jayoung Jeong5 and Ken Donaldson1*Abstract
Background: Hazard identification for risk assessment of nanoparticles (NPs) is mainly composed of in vitro cell-
based assays and in vivo animal experimentation. The rapidly increasing number and functionalizations of NPs
makes in vivo toxicity tests undesirable on both ethical and financial grounds, creating an urgent need for
development of in vitro cell-based assays that accurately predict in vivo toxicity and facilitate safe nanotechnology.
Methods: In this study, we used 9 different NPs (CeO2, TiO2, carbon black, SiO2, NiO, Co3O4, Cr2O3, CuO, and ZnO).
As an in vivo toxicity endpoint, the acute lung inflammogenicity in a rat instillation model was compared with the
in vitro toxicity endpoints comprising cytotoxicity, pro-inflammatory cytokine expression, or haemolytic potential.
For in vitro assays, 8 different cell-based assays were used including epithelial cells, monocytic/macrophage cells,
human erythrocytes, and combined culture.
Results: ZnO and CuO NPs acting via soluble toxic ions showed positive results in most of assays and were
consistent with the lung inflammation data. When compared in in vitro assays at the same surface area dose
(30 cm2/mL), NPs that were low solubility and therefore acting via surface reactivity had no convincing activity,
except for CeO2 NP. Cytotoxicity in differentiated peripheral blood mononuclear cells was the most accurate
showing 89% accuracy and 11% false negativity in predicting acute lung inflammogenicity. However, the
haemolysis assay showed 100% consistency with the lung inflammation if any dose, having statistical significance
was considered positivity. Other cell-based in vitro assays showed a poorer correlation with in vivo
inflammogenicity.
Conclusions: Based on the toxicity mechanisms of NPs, two different approaches can be applied for prediction of
in vivo lung inflammogenicity. Most in vitro assays were good at detecting NPs that act via soluble ions (i.e., ZnO
and CuO NP). However, in vitro assays were limited in detecting NPs acting via surface reactivity as their mechanism
of toxicity, except for the haemolysis assay.
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Metal oxide nanoparticles (NPs) have been used in vari-
ous applications including industrial, electrical, pharma-
ceutical, and biomedical fields because of their unique
physicochemical properties compared to bulk chemicals
[1]. The high production volume of NPs and increasing
numbers of functionalized versions constitutes a burden
for toxicity testing and risk assessment for NP exposures
[2]. In response to increasing concerns about the safety
of manufactured nanomaterials, OECD (Organisation
for Economic Co-operation and Development) launched
an internationally harmonised programme about hazard,
exposure, and risk assessment of nanomaterials in 2006
[3]. After six years of work, the OECD has come to con-
clusion that the current testing approaches are generally
acceptable for nanomaterials although some adoptions
may be necessary for the certain Test Guidelines [4].
Current hazard identification for risk assessment of
NPs is mainly conducted with the aid of both in vivo
and in vitro toxicity approaches. In vivo animal experi-
mentation is more informative than in vitro experimen-
tation, but there are major ethical and financial
limitations to the in vivo approach [5]. Therefore,
in vitro assay have been suggested as an alternative
method to in vivo testing; indeed in vitro experiments
are often used as an initial screen for the toxicity of sub-
stances and evaluation of their toxic mechanisms. There
are several in vitro cell-based testing methods that are
frequently used in this setting, including some assays
which combine several cell types [6], and others that use
differentiated macrophages from monocytic cells, which
are more sensitive to weak stimuli [7]. However, in re-
cent studies comparing several cell lines, cells were found
to respond differently to NPs depending on the physio-
logical functions and activities of cells [8,9] and failed to
predict the in vivo lung inflammogenicity [10]. However,
those studies were performed with a limited number of
particles and cell assays; more profound studies are es-
sential to correlate in vitro and in vivo toxicity assays.
There are several critical factors that can produce dis-
crepancies between studies. Dose is one of the most im-
portant factors when comparing several in vitro assays
with in vivo assays, because even NPs with low toxicity
can be toxic at high doses [11]. Surface area has been
suggested as an appropriate dose metric in nanotoxicol-
ogy rather than mass [12]. In addition to surface area
metric, the dispersion of NPs is very important because
highly agglomerated NPs showed less toxicity or
inflammogenicity compared to well-dispersed NPs [13].
Determining the target organ for NP exposure is also
important for selection of appropriate cell types for
in vitro assays.
In this study, we were concerned with inhalation ex-
posure of metal oxide NPs in occupational or consumersettings and we therefore used an acute lung inflamma-
tion model by intratracheal instillation into the lungs of
rats. By comparison, we chose to investigate the nano-
toxicity of the same panel of NPs in lung alveolar and
bronchial epithelial cells and monocytic or macrophage
cells to mimic the in vivo lung environment, using a
range of in vitro toxicity tests.
Results
Characterization of NPs
Table 1 summarize the characterization of NPs including
primary size, hydrodynamic size, and surface area. All
NPs in PBS formed agglomerates, which required sonic-
ation to be dispersed. However, inclusion of 5% fetal
bovine serum in the PBS, particles formed smaller ag-
glomerates that were readily dispersed because of the
protein corona on the surface of NPs. All NPs and FBS
showed endotoxin levels below the detection limit.
A549 cells
Cr2O3, ZnO, and CuO NPs showed significant cytotox-
icity (cell death measured by LDH levels or trypan blue
staining) compared with vehicle control whilst other
NPs had little or no toxic effect in this assay at the doses
tested (30–300 cm2/mL for most NPs, 3–30 cm2/mL for
ZnO and CuO; Figure 1A). The levels of IL-8 proteins in
the supernatant were significantly increased by both
ZnO and CuO NP (Figure 1B). Note that ZnO and CuO
NP were the most cytotoxic and stimulatory for IL-8
although they were used at doses 10-fold less than the
other NPs.
16-HBE cells
Only ZnO and CuO NP exposure significantly increased
cytotoxicity to 16-HBE cells (Figure 2A). The levels of
IL-8 proteins were significantly increased by CeO2, car-
bon black (CB), and ZnO NP and significantly decreased
by TiO2 NP at the high dose (Figure 2B).
Monocytic THP-1 cells
Cr2O3 and CuO NP exposure significantly increased
cytotoxicity, whilst other NPs showed no differences
compared to vehicle control (Figure 3A). The levels of
IL-1β protein significantly increased only with TiO2 NP
treatment (Figure 3B).
Alveolar macrophages
Rat alveolar macrophages showed greater sensitivity to
NPs compared to cell lines. All NPs excluding CB and
SiO2 showed significant cytotoxicity compared to vehicle
control (Figure 4A). In comparison with cytotoxicity,
the levels of IL-1β showed marginal responses which
only TiO2 and CuO NP showing significant increases
(Figure 4B), although it should be noted that the TiO2
Table 1 Physicochemical properties of the panel of nanoparticles
NPa Primary size (nm)b Surface area (m2/g)c Hydrodynamic size (nm) in 5% FBS Mass (μg) for 30 cm2
CeO2 9.7 ± 0.4 24.1 69.3 ± 8.0 125
TiO2-rutile 30.5 ± 1.8 27.5 89.9 ± 13.1 109
CB 15.3 ± 6.0 254 45.1 ± 9.8 11.8
SiO2 6.2 ± 0.4 523.4 398.1 ± 24.8 5.0
NiO 5.3 ± 0.4 91.8 100.8 ± 38.5 32.7
Co3O4 18.4 ± 0.8 35.8 148.2 ± 95.5 83.8
Cr2O3 205 ± 20.7 74.42 195.3 ± 101.4 40.3
ZnO 10.7 ± 0.7 48.2 492.8 ± 25.2 62.0
CuO 23.1 ± 1.0 29 95.6 ± 1.6 103
aNPs were provided by Nanostructural and Amorphous Materials Inc. (Houston, TX, USA) except for CB (Evonik Degussa GmbH, Frankfurt, Germany),
ZnO (NanoScale Corporation, Manhattan, KS, USA), and CuO (Sigma-Aldrich).
bPrimary particle sizes were measured by a transmission electron microscopy.
cSurface area was measured by BET (Brunauer-Emmett-Teller) method.
Figure 1 Cytotoxicity and IL-8 expression of A549 cells after exposure to NPs for 24 h. (A) Cytotoxicity was measured by trypan blue
exclusion for ZnO and CuO NP whilst others were measured by LDH. (B) Levels of IL-8 of A549 cells at 24 h following treatment. Note that the
surface area doses were 30, 100, and 300 cm2/mL except for ZnO and CuO NP which were 3, 10, and 30 cm2/mL. Values are mean ± SD from
minimum four independent experiments. Significance versus vehicle control (VEH): *p < 0.05, ***p < 0.001.
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Figure 2 Cytotoxicity and IL-8 expression of 16-HBE cells after exposure to NPs for 24 h. (A) Cytotoxicity was measured by trypan blue
exclusion for ZnO and CuO NP whilst others were measured by LDH. (B) Levels of IL-8 of 16-HBE cells at 24 h following treatment. Note that the
surface area doses were 30, 100, and 300 cm2/mL except for ZnO and CuO NP which were 3, 10, and 30 cm2/mL. Values are mean ± SD from
minimum four independent experiments. Significance versus vehicle control (VEH): *p < 0.05, ***p < 0.001.
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of 10 cm2/mL of CuO NP was approximately equipotent
for IL-1β.
Peripheral blood monocyte-derived macrophages
(PBMDM)
PBMDM were differentiated from the peripheral blood
mononuclear cells (PBMC) by culturing for 5 days. All
NPs excluding CeO2, TiO2, and SiO2 NP showed
significant cytotoxicity compared to vehicle control
(Figure 5A). The levels of IL-1β were significantly
increased by TiO2, CB, NiO, Cr2O3, and ZnO NP
(Figure 5B). The levels of TNF-α were significantly in-
creased by TiO2 and ZnO NP whilst other NPs were
comparable with vehicle control (Figure 5C).
Differentiated THP-1 cells
Differentiated THP-1 cells by treatment with phorbol
myristate acetate (PMA) showed much greater sensitivitycompared to monocytic THP-1 cells. CeO2, TiO2, NiO,
Cr2O3, ZnO, and CuO NP showed significantly increased
cytotoxicity compared to vehicle control (Figure 6A). The
use of differential doses, however, again revealed that ZnO
and CuO NP were an order of magnitude or more cyto-
toxic than the others. Levels of IL-1β were increased in
CeO2 and TiO2 NP-treated cells and showed modest in-
creases with CB, SiO2, Co3O4, and Cr2O3 NP (Figure 6B).
In contrast, the levels of TNF-α showed marked increases
on treatment with CeO2 and NiO NP and slight increases
by TiO2 and Cr2O3 NP (Figure 6C). Treatment of cytocha-
lasin D, a well characterized inhibitor of phagocytosis, dra-
matically inhibited the expression of IL-1β showing around
1/15 and 1/7 reductions for CeO2 and TiO2 NP compared
to the same treatment without cytochalasin D (Figures 6D).
Combined culture
The levels of IL-8 in the conditioned media from THP-1
cells before addition of A549 cells were significantly
Figure 3 Cytotoxicity and IL-1β expression of monocytic THP-1 cells after exposure to NPs for 24 h. (A) Cytotoxicity was measured by
trypan blue exclusion for ZnO and CuO NP whilst others were measured by LDH. (B) Levels of IL-1β of monocytic THP-1 cells at 24 h following
treatment. Note that the surface area doses were 30, 100, and 300 cm2/mL except for ZnO and CuO NP which were 3, 10, and 30 cm2/mL. Values
are mean ± SD from minimum four independent experiments. Significance versus vehicle control (VEH): *p < 0.05, **p < 0.01, ***p < 0.001.
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(Figure 7A). Addition of NP-free conditioned media to
A549 cells produced a marked increase in IL-8 levels in
the CeO2, TiO2, Cr2O3, ZnO, and CuO NP treatment
groups (Figure 7B). Compared with single treatment to
A549 cells presented in Figure 1B, conditioned medium
produced more sensitive and higher responses for the
IL-8 production.Haemolysis assay
CeO2, NiO, Co3O4, and CuO NP showed significant
haemolytic potential compared to vehicle control (Figure 8)
and all were tested at equal surface area dose. However, it
was notable that there was a real difference in potency with
NiO NP being at least 2 times more potent than the others
in all treatment doses.Correlation of in vitro assays with in vivo acute lung
inflammogenicity
Table 2 summarise the number of total granulocytes in the
bronchoalveolar lavage fluid in the lungs of rats treated at
150 cm2/rat after 24 h of instillation. Table 3 summarise
the utility of the various in vitro assays for predicting lung
inflammogenicity of NP panel. Because the gold standard
for comparison between lung inflammation and several
in vitro assays was dosed at equal surface area dose, we
took the 30 cm2/mL dose as the measure of a significant
effect. Cytotoxicity in differentiated PBMC (PBMDM)
showed the best accuracy - 89% (8/9) accuracy, 11% (1/9)
false negativity, and 0% (0/9) false positivity to predict
acute lung inflammogenicity. The second best assay was
cytotoxicity using primary cultured alveolar macrophages
which showed 78% (7/9) accuracy, 11% (1/9) false negativ-
ity, and 11% (1/9) false positivity. Data from other cell
Figure 4 Cytotoxicity and IL-1β expression of primary cultured alveolar macrophages after exposure to NPs for 24 h. (A) Cytotoxicity
was measured by trypan blue exclusion for ZnO and CuO NP whilst others were measured by LDH. (B) Levels of IL-1β of primary cultured
alveolar macrophages at 24 h following treatment. Note that the surface area doses were 30, 100, and 300 cm2/mL except for ZnO and CuO NP
which were 3, 10, and 30 cm2/mL. Values are mean ± SD from minimum four independent experiments. Significance versus vehicle control (VEH):
*p < 0.05, **p < 0.01, ***p < 0.001.
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and alveolar macrophages showed a poor correlation with
in vivo lung inflammogenicity. In contrast, the in vitro
assay data at any dose that have statistical significance
showed that the haemolysis assay was the most accurate
(Table 4). Table 3 can also suggest the mechanisms of ac-
tion of various metal oxide NPs. Among the NP that
caused inflammation, CeO2 NP had a range of activities
causing IL-8 release from 16-HBE, toxicity to alveolar mac-
rophages, and TNF-α release from THP-1 cells. NiO NP
show no persuasive effects whilst Co3O4 NP seemed to kill
macrophages without stimulating them. TiO2, CB, SiO2,
and Cr2O3 NP showed no convincing effects whilst ZnO
and CuO NP caused significant changes in most of assays.
Discussion
Cell-based in vitro toxicity testing is very important not
only for evaluation of mechanism of action but also foralternative testing methods to replace animal experimen-
tation [14]. In nanotoxicology, in vitro toxicity testing for
NPs has a high priority and indeed most of the studies
have been conducted in vitro [15]. However, the responses
to NPs are known to be very variable depending on cell
type because of the diverse physiological functions of cells
and the heterogeneous physicochemical properties of NPs
[8]. In this study, we used 9 predominantly metal oxide
NPs and tested cytotoxicity and pro-inflammatory cyto-
kine expression using 8 different cell-based toxicity testing
models relevant to the lung. The efficacy of in vitro testing
methods was evaluated against the potential of the panel
to cause acute lung inflammation in rats using data that
we published previously [16,17]. All NPs used in in vivo
and in vitro study were exactly same batch and both stud-
ies were performed contemporaneously.
Differentiated THP-1 cells by PMA treatment were
considerably more sensitive to NPs with respect to both
Figure 5 Cytotoxicity and pro-inflammatory cytokine expression of differentiated PBMC after exposure to NPs for 24 h. (A) Cytotoxicity
was measured by trypan blue exclusion for ZnO and CuO NP whilst others were measured by LDH. (B) Levels of IL-1β; (C) levels of TNF-α. PBMC
were differentiated by 5-day incubation. Note that the surface area doses were 30, 100, and 300 cm2/mL except for ZnO and CuO NP which were
3, 10, and 30 cm2/mL. Values are mean ± SD from minimum four independent experiments. Significance versus vehicle control (VEH): *p < 0.05,
**p < 0.01, ***p < 0.001.
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ferentiated THP-1 cells. The pattern of IL-1β expression
was slightly different from that of TNF-α. For example,
TiO2 NP induced the greatest response with respect to
IL-1β but only a slight increase in TNF-α; NiO NP on
the other hand did not increase IL-1β but caused a sub-
stantial increase in TNF-α levels. This might mean that
each metal oxide triggers inflammation by different
pathways, possibly resulting in different modes of in-
flammation depending on their physicochemical proper-
ties [16]. Interestingly ZnO and CuO NP failed to
induce any cytokines response but were found to be
highly cytotoxic. The cytotoxicity of ZnO and CuO NP
is likely due to their water soluble ions [18]. In addition
to this, accelerated dissolution of ZnO [19] and CuO NP
[20] inside of the acidic lysosomal fluid might be more
effective in macrophages compared to monocytic cells.
Several NPs such as SiO2 and TiO2 NP were recently
known to cause release of IL-1β by activating NLR pyrin
domain containing 3 (Nlrp3) inflammasome [21,22].
However, ZnO NP did not activate the Nlrp3 inflamma-
some and failed to stimulate release of IL-1β and themechanism of inflammasome activation was poorly
understood [21]. The pH-dependent dissolution of ZnO
and CuO NP inside phagolysosomes causes the NPs to
lose the physico-chemical properties that might influ-
ence the phagocytosis-related inflammasome activation
and pro-inflammatory cytokine expression. The expres-
sion of IL-1β by NPs was markedly reduced by inhibition
of phagocytosis using cytochalasin D. Therefore, phago-
cytosis is an important mechanism of producing IL-1β
by activation of inflammasome. TNF-α is another im-
portant pro-inflammatory cytokine driving inflammation
in the lung and CeO2 and NiO NP, the two NPs highly
responsive to TNF-α, was consistent with the inflammo-
genicity in the lung [16].
Treatment of A549 cells with NP-free conditioned
medium from THP-1 cells (combined culture) showed
much greater response in IL-8 production compared to
the direct particle exposure. The increases of IL-8 in
A549 cells caused by CeO2, TiO2, and Cr2O3 NP in the
combined culture were mainly due to the TNF-α and IL-
1β released by THP-1 cells. The increased IL-8 levels re-
leased by A549 cells on treatment with ZnO and CuO
Figure 6 Cytotoxicity and pro-inflammatory cytokine expression of differentiated THP-1 cells after exposure to NPs for 24 h. (A)
Cytotoxicity was measured by trypan blue exclusion for ZnO and CuO NP whilst others were measured by LDH. (B) Levels of IL-1β; (C) levels of
TNF-α. (D) Treatment of NP with cytochalasin D (0.2 μM) showed marked decrease of IL-1β expression compared to NP without cytochalasin D
(B). THP-1 cells were differentiated by treatment with PMA (10 ng/mL) and NPs were treated at 30, 100, and 300 cm2/mL except for ZnO NP
(3, 10, and 30 cm2/mL) and CuO NP (0.3, 1, and 3 cm2/mL). Values are mean ± SD from minimum four independent experiments. Significance
versus vehicle control (VEH): *p < 0.05, **p < 0.01, ***p < 0.001.
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the release of water soluble metal ions by THP-1 cells.
Although the combined culture is a good method to
evaluate the action of pro-inflammatory cytokines re-
leased from one cell type on another cell type [23-25],
the toxic ions released from soluble NPs also should be
carefully taken into account in this assay [18].
In our previous studies we reported that the CeO2,
NiO, and Co3O4 NP had surface charge as their bio-
logically effective dose (BED) whilst ZnO and CuO NP
had soluble toxic ions as their BED [26,27]. When NPs
were inhaled, NPs gain a protein corona and so the sur-
face charge might be blocked and the toxicities mitigated
[28]. However, the protein corona may have little role
with NPs which dissolve in acidic conditions [26]. This
might be the reason why the most of in vitro assay data
of ZnO and CuO NP are consistent with the lung in-
flammation data.
When NPs were dosed at 30 cm2/mL which is the only
overlapping dose between NPs, the cytotoxicity in
differentiated peripheral blood mononuclear cells was
the most consistent with the lung inflammation data. Inaddition, haemolysis assay showed the best accuracy
(100%) when haemolysis at any dose was taken to repre-
sent positivity in the assay. The haemolysis assay has
been proposed as a good model for prediction of in vivo
lung inflammation [29]. However, haemolysis assay is
not applicable to NPs like ZnO which have high binding
affinity with haemoglobin and small-sized well-dispersed
NPs which need ultracentrifugation to get rid of NPs. In
addition, the haemolysis assay should use protein-free
saline as a vehicle because protein corona protects the
surface reactivity in cell culture condition [26,30,31].
Although both cell culture and in vivo condition can
produce a corona, the surface reactivity might be
unmasked more fully in vivo [26] but unmasking might
be variable in in vitro depending on the cell types and
culture conditions. This might be due to the differences
in the enzymatic activity inside of phagolysosomes
between each model [32] and synergistic effect by cross-
talking between each cell type. Among 8 different
in vitro systems, alveolar macrophages, differentiated
PBMC, and red blood cells were better for prediction of
in vivo lung inflammogenicity of NPs than other
Figure 7 IL-8 expression by NP-conditioned media. A549 cells were exposed to conditioned media from NP-exposed differentiated THP-1
cells for 4 h. THP-1 cells were differentiated by treatment for PMA (10 ng/mL) and NPs were treated at surface area doses of 30, 100, and
300 cm2/mL except for ZnO NP (3, 10, and 30 cm2/mL) and CuO NP (0.3, 1, and 3 cm2/mL). (A) The levels of IL-8 in the conditioned media from
THP-1 cells before addition of A549 cells. (B) The levels of IL-8 after addition of NP-free conditioned media to A549 cells. Values are mean ± SD
from minimum four independent experiments. Significance versus vehicle control (VEH): ***p < 0.001.
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toxicity assay can be suggested for better parameters for
correlation with in vivo lung inflammogenicity than pro-
inflammatory cytokine assay.Conclusions
Based on the toxicity mechanisms of NPs, two different
approaches can be applied for prediction of in vivo lung
inflammogenicity. Most in vitro assays may detect toxic
or inflammogenic potential of NPs if the NPs act via sol-
uble ions (i.e., ZnO and CuO NP). However, in vitro as-
says appear not to be good at detecting metal oxide NPs
that act via surface charge as their mechanism of tox-
icity, with the key exception of haemolysis.Materials and methods
Nanoparticle and characterization
A total of 9 different predominantly metal oxide NPs
[CeO2, TiO2 (rutile form), carbon black (CB), SiO2, NiO,
Co3O4, Cr2O3, CuO, and ZnO] were purchased from
commercial sources (Table 1). The primary size of NP
was measured by transmission electron microscopy
(TEM) (JEM-1200EX II, JEOL, Tokyo, Japan). The sur-
face area (BET, Brunauer-Emmett-Teller) of NPs was
measured using a Micromeritics TriStar 3000 (Bedford-
shire, UK). Agglomeration status of NP in PBS with/
without dispersion medium (fetal bovine serum, FBS)
was measured by dynamic light scattering (Brookhaven
90 plus; Holtsville, NY, USA). Endotoxin levels in NP
suspensions were evaluated by an endpoint chromogenic
Figure 8 Haemolysis assay of NP. NPs were treated at surface area
doses of 30, 100, and 300 cm2/mL. Values are mean ± SD from
minimum four independent experiments. Significance versus vehicle
control (VEH): *p < 0.05, ***p < 0.001.
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USA). The detection limit of LAL kit was 0.1 – 1.0 EU/ml.
Rationale for dose selection
All experiments were performed using surface area as a
dose metric because surface area is considered to be the
most appropriate metric for assessing NP toxicity in vivo
and in vitro [12]. For in vitro assays, we performed pre-
liminary dose-ranging studies for all NPs from 0.1 to
300 cm2/mL. Based on their cytotoxicity, all NPs were
used at doses of 30, 100, and 300 cm2/mL, except for
CuO and ZnO NPs, which were treated at 3, 10, 30 cm2/
mL because of their greater toxicity. In our previous
studies, NPs were intratracheally instilled into the lungs
of female Wistar rats at 50, 150, 250 cm2/mL [16,17,29].
As a result, CeO2 and NiO NP were inflammogenic
from 150 cm2/mL and ZnO and CuO NP were inflam-
mogenic from 50 cm2/mL. Treatment of TiO2, CB, SiO2Table 2 The number of total granulocytes in the BAL at
24 h after instillation of NPs into rats
NP Total cells (×105) Granulocytes (×105)
Vehicle control 7.5 ± 3.1 0.2 ± 0.1
CeO2 42.3 ± 25.9** 37.1 ± 23.2***
TiO2-rutile 7.6 ± 2.6 1.5 ± 1.8
CB 13.1 ± 4.4 8.0 ± 3.3
SiO2 6.1 ± 1.0 0.5 ± 0.7
NiO 45.5 ± 16.8** 35.0 ± 17.0***
Co3O4 104.4 ± 12.4*** 93.8 ± 11.3***
Cr2O3 39.9 ± 12.1** 1.7 ± 1.6
ZnO 16.0 ± 4.1 13.2 ± 5.0*
CuO 40.5 ± 3.6** 36.9 ± 3.8***
The acute lung inflammogenicity data were used from our previously
published data [16,17].
Significance versus vehicle control: *p < 0.05, **p < 0.01, ***p < 0.001.did not show any significant inflammation. Therefore,
we selected 150 cm2/mL for acute lung inflammation
because NiO NP is well known as toxic particles in hu-
man cell lines [33] and in rats [34]. To evaluate the cor-
relation of in vitro data against in vivo data, the dose for
in vivo was fixed at 150 cm2/mL and compared with
in vitro data at various doses.Dispersion of NPs
Because NPs showed some agglomerates which are not
readily dispersed without any stresses (i.e., sonication) in
PBS, NPs were dispersed with 5% FBS which provide a
protein corona on the surface of particles as previously
described method [16].Cell culture
When NPs are inhaled, they immediately interact with
epithelial cells and then alveolar macrophages. Red
blood cells have been used in particle toxicology studies
to determine direct membranolytic effects of particle
surfaces and we emphasise that interactions with red
blood cells are not part of the pathophysiological
mechanism by which NP act. Therefore we selected
alveolar epithelial cells – A549 cells, bronchial epithelial
cells – 16-HBE cells, monocytic/macrophage cells –
THP-1 cells, human peripheral blood mononuclear cells
(PBMC), and rat alveolar macrophages and human red
blood cells. A549 cells were obtained from the European
Collection of Animal Cell Cultures and THP-1 cells
were purchased from American Type Culture Collection
(ATCC). 16-HBE cells originated from Dr. Gruenert of
the University of California, San Francisco, USA [35].
Rat alveolar macrophages underwent primary culture
following whole lung lavage in 7-week old healthy female
Wistar rats. Human peripheral whole blood was col-
lected from healthy consenting volunteers (University of
Edinburgh) and PBMC were then isolated from buffy
coats according to the previously described method [36].
A549 cells and 16-HBE cells were cultured in DMEM
medium containing 5% FBS and THP-1 cells, PBMC,
and rat alveolar macrophages were cultured in RPMI-
1640 medium containing 10% FBS. Cells were cultured
at 37°C with 5% CO2, 2 mM L-glutamine (Life Tech-
nologies, Paisley, UK), 100 IU/mL penicillin, and 100 U/
mL streptomycin (Life Technologies). The number of
cells for seeding to 6-well plate was 2 × 105 cells/mL for
A549 cells and 16-HBE cells and 1 × 106 cells/mL for
monocytic/macrophage cells. The monocytic THP-1
cells were differentiated to macrophages with 10 ng/mL
of phorbol myristate acetate (PMA; Sigma-Aldrich,
Gillingham, Dorset, UK) for 2 days and Peripheral blood
monocyte-derived macrophages (PBMDM) were differ-
entiated from PBMC by culturing for 5 days. After
Table 3 Comparison of in vivo lung inflammation data with in vitro assay data at the same surface area dose (30 cm2/mL) unless otherwise stated
Rat (150 cm2/rat) A549 16-HBE THP-1 Alveolar mac Differentiated PBMC DifferentiatedTHP-1a Combined (A549 + THP-1)a Haemolysis
granulocytes cytotoxb IL-8 cytotox IL-8 cytotox IL-1β cytotox IL-1β cytotox IL-1β TNF-α cytotox IL-1β TNF-α IL-8 % haemolysis
CeO2 + - - - + - - + - - - - - - + - -
TiO2-rutile - - - - - - - - - - - - - + - - -
CB - - - - + - - - - - - - - - - - -
SiO2 - - - - - - - - - - - - - - - - -
NiO + - - - - - - - - + - - - - - - +
Co3O4 + - - - - - - + - + - - - - - - -
Cr2O3 - - - - - - - + - - - - - - - - -
ZnO + + + + + - - + - + + + + - - + N/A
CuO + + + + - + - + + + - - + - - + -
Accuracy 6/9 6/9 6/9 5/9 5/9 4/9 7/9 5/9 8/9 5/9 5/9 6/9 3/9 5/9 6/9 5/8
False positive 0/9 0/9 0/9 1/9 0/9 0/9 1/9 0/9 0/9 0/9 0/9 0/9 1/9 0/9 0/9 0/8
False negative 3/9 3/9 3/9 3/9 4/9 5/9 1/9 4/9 1/9 4/9 4/9 3/9 5/9 4/9 3/9 3/8
aThe highest dose for CuO NP was 3 cm2/mL.
bCytotoxicity was measured by lactated dehydrogenase (LDH) or trypan blue exclusion assay.
Minimum four independent experiments were performed for each assay.
Statistically significant changes compared to vehicle control were marked as ‘+’ and no significant changes were noted as ‘-’.
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Table 4 Comparison of in vivo lung inflammation data with in vitro assay data based on any dose even implausibly high ones
Rat (150 cm2/rat) A549 16-HBE THP-1 Alveolar mac Differentiated PBMC Differentiated THP-1a Combined (A549 + THP-1)a Haemolysis
granulocytes cytotoxb IL-8 cytotox IL-8 cytotox IL-1β cytotox IL-1β cytotox IL-1β TNF-α cytotox IL-1β TNF-α IL-8 % haemolysis
CeO2 + - - - + - - + - - - - + + + + +
TiO2-rutile - - - - - - + + + - + + + + + + -
CB - - - - + - - - - + + - - + - - -
SiO2 - - - - - - - - - - - - - + - - -
NiO + - - - - - - + - + + - + - + - +
Co3O4 + - - - - - - + - + - - - + - - +
Cr2O3 - + - - - + - + - + + - + + + + -
ZnO + + + + + - - + - + + + + - - + N/A
CuO + + + + - + - + + + - - + - - + +
Accuracy 5/9 6/9 6/9 5/9 4/9 3/9 7/9 4/9 6/9 3/9 4/9 6/9 2/9 4/9 5/9 8/8
False positive 1/9 0/9 0/9 1/9 1/9 1/9 2/9 1/9 2/9 3/9 1/9 2/9 4/9 2/9 2/9 0/8
False negative 3/9 3/9 3/9 3/9 4/9 5/9 0/9 4/9 1/9 3/9 4/9 1/9 3/9 3/9 2/9 0/8
aThe highest dose for CuO NP was 3 cm2/mL.
bCytotoxicity was measured by lactated dehydrogenase (LDH) or trypan blue exclusion assay.
The statistically significant changes compared to vehicle control were marked as ‘+’ and no significant changes were noted as ‘-’.
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and NPs were treated.
Inhibition of phagocytosis by cytochalasin D
To evaluate the role of phagocytosis on the pro-
inflammatory cytokine release, we treated cytochalasin D
which is a well characterized inhibitor of phagocytosis.
After differentiation of THP-1 cells by PMA, 0.2 μM of
cytochalasin D (Enzo Life Sciences, Exeter, UK) were
added to NP suspensions and treated for 24 h. The cell
supernatants were then collected for lactate dehydrogen-
ase (LDH) and cytokine measurement.
NP treatment and measurement of cytotoxicity
Three different doses of NPs were dispersed in FBS first
with the volume of 5% in working solution and cell cul-
ture medium was added as described above. NPs were
then added to cell cultures and incubated for 24 h. Cyto-
toxicity was measured using a lactate dehydrogenase
(LDH) assay kit (Roche Diagnostics Ltd., Burgess Hill,
UK) in the NP-free cell culture supernatant collected by
three rounds of centrifugation at 15000 × g for 20 min.
Vehicle control and 0.1% Triton-X treatment were used
as a negative and positive control, respectively. The cyto-
toxicity of NP was expressed by percentage compared to
complete cytotoxicity (0.1% Triton-X). To evaluate the
adsorption of LDH on the NPs, bare NPs (NPs alone) or
NPs pre-incubated in 5% FBS to give them a protein cor-
ona were incubated with A549 cell extract rich in LDH
and LDH assay was then performed. Briefly, NPs with or
without 5% FBS at the highest doses used in in vitro
study (30 or 300 cm2/mL) were incubated with 0.1%
Triton-X treated A549 cells for 30 min at room
temperature. LDH assay was performed using NP
containing-cell lysate solution according to the instruc-
tion manual (Roche Diagnostics Ltd.). After colour de-
velopment, solutions were centrifuged at 15000 ×g for
20 min to get rid of NPs and measured absorbance at
490 nm. As a result, bare NPs showed variable adsorp-
tion with some NP adsorbing LDH, whilst NPs with a
protein corona showed minimal adsorption (data not
shown). Therefore, the adsorption of LDH on the NP
with a corona is minimal in this setting. Some metal ions
released from NPs are known to inhibit the color devel-
opment of LDH assay [37]. In our panel of NPs, trypan
blue exclusion test was applied to ZnO and CuO NP
owing to this interference.
Combined cell culture
Because one of the critical components of the inflamma-
tory response induced by NPs in the lung is the release
of inflammatory mediators in contact with alveolar mac-
rophages, we treated conditioned medium of THP-1
cells to A549 cells by modification of the previouslydescribed method [25]. Briefly, differentiated THP-1
cells by PMA as mentioned above were treated with NPs
for 24 h. NP-free supernatant was then prepared by
three rounds of centrifugation at 15000 ×g for 20 min
and treated to A549 cells for 4 h. After 4 h of incuba-
tion, medium was washed with PBS for three times and
replaced with fresh DMEM medium and incubated for
an additional 20 h.
Measurement of cytokines (IL-1β, IL-8, and TNF-α)
IL-1β, IL-8, and TNF-α are pro-inflammatory cytokines
correlated with inflammogenic potential of particles [38].
We measured IL-8 protein levels in the supernatant of
A549 cells, 16-HBE cells, and combined culture and IL-1β
and TNF-α in supernatants of monocytes/macrophages
cells (THP-1 cells, PBMDM, and alveolar macrophages)
according to the instruction manual (R&D Systems).
Haemolysis assay
Haemolysis assay was performed according to the previ-
ously described method [29]. Briefly, human red blood
cells were incubated with NPs at 30, 100, and 300 cm2/mL
dispersed in saline without any proteins. Saline and 0.1%
Triton X-100 was used as negative and positive control,
respectively. After 30 min incubation, the amount of
released haemoglobin was determined by absorbance at
λ = 550 nm. ZnO NP was excluded in this assay owing to
high binding affinity with haemoglobin [26].
Correlation of in vitro assays with in vivo acute lung
inflammogenicity
To evaluate the correlation of in vitro assays with in vivo
toxicity, we used some previously published animal ex-
perimental data from our own group [16,17] in order to
avoid unnecessary sacrifice of animals. Although in vivo
data were published earlier, both studies were performed
at the same time with the same batch of NPs. The num-
ber of total granulocytes was selected as a marker for
acute lung inflammogenicity. For in vitro assays, statisti-
cally significant increases in any doses were regarded as
“positive” and other cases were regarded as “negative”
(i.e. no effect). For in vivo experiments, statistically sig-
nificant increases in the number of total granulocytes
compared to vehicle control were regarded as “positive”.
Because one of the most important parameter compar-
ing each result was the treatment dose, we compared
in vitro assays at 30 cm2/mL (the only overlapping dose
used for all the particles except in Figures 6 and 7 where
3 cm2/mL was the highest dose for CuO NP) or any
dose showing statistical significance.
Statistical analysis
We conducted minimum 4 individual experiments and
all data were expressed as mean ± standard deviations.
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Pad Software, Inc., La Jolla, CA, USA). One-way analysis
of variance with post hoc Tukey’s pairwise comparisons
test was used to compare the differences between
groups. A p value of < 0.05 was considered to be statisti-
cally significant.
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